Our data revealed an increase in JAM-A protein expression in patient tumor cultures compared with non-tumor cultures, corroborating our previous study observing JAM-A overexpression in invasive breast cancer tissue microarrays [19]. The gene discussed is F11R; the disease is breast carcinoma.